IMARC Group has recently released a new research study titled "United States Pharmacy Market Report by Product Type (Prescription, OTC), Pharmacy Type (Hospital Pharmacy, Retail Pharmacy, ePharmacy, and Others), Ownership (Independent, Chain), and Region 2026-2034", offering a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

United States Pharmacy Market Size & Share 2026-2034

The United States pharmacy market size reached USD 668.3 Billion in 2025 and is projected to reach USD 937.4 Billion by 2034, expanding at a CAGR of 3.72% during 2026-2034. In 2026, the market continues to gain momentum, shaped by the rising incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions, an aging population, and the growing adoption of ePharmacy and digital health solutions.

Growth in 2026 is further reinforced by the expanding role of pharmacists in patient-centered care, including immunizations, medication counseling, and chronic disease management, along with ongoing advancements in medical research and specialty drug development. These dynamics are expected to strengthen the United States pharmacy market share throughout the forecast period.

Key Market Statistics at a Glance

• Base Year: 2025
• Historical Years: 2020-2025
• Forecast Period: 2026-2034
• Market Size (2025): USD 668.3 Billion
• Projected Market Size (2034): USD 937.4 Billion
• Growth Rate: CAGR of 3.72% (2026-2034)

Explore Opportunities in the United States Pharmacy Market: Download the IMARC Sample Report: https://www.imarcgroup.com/united-states-pharmacy-market/requestsample

Key Growth Drivers and Trends in the United States Pharmacy Market

Growth in the United States pharmacy market is being driven primarily by the increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. As the burden of these long-term conditions rises, fueled by lifestyle changes and environmental factors, demand for a diverse range of medications continues to grow.

One of the leading United States pharmacy market trends is the aging demographic. The elderly typically require a higher volume of medications and healthcare services, contributing substantially to prescription volumes. This is complemented by a growing regional population, rising healthcare awareness, and increased access to healthcare services, all of which sustain upward pressure on demand for pharmaceutical products.

Another key factor supporting United States pharmacy market growth is the expanding role of e-commerce and digital health solutions. Online pharmacies and telehealth platforms are gaining traction, offering consumers a convenient and efficient way to fulfill their healthcare needs. In parallel, advancements in medical research and technology, the development of specialty drugs, personalized medicine, and the expansion of retail pharmacy chains are shaping the future dynamics of the market.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=21066&flag=C

United States Pharmacy Industry Segmentation Insights

Breakup by Product Type:

• Prescription: Medications dispensed only on a prescription from a licensed healthcare provider, covering chronic, acute, and specialty therapies.
• OTC: Over-the-counter medicines that consumers can purchase without a prescription for common and self-treatable conditions.

Breakup by Pharmacy Type:

• Hospital Pharmacy: Pharmacies operating within hospitals and health systems, supplying medications for inpatient care and outpatient needs.
• Retail Pharmacy: Community and drugstore pharmacies that dispense prescriptions and sell OTC products, and provide services such as counseling and immunizations.
• ePharmacy: Online pharmacies and digital platforms that enable customers to order prescription and OTC products for home delivery.
• Others: Includes other dispensing channels such as mail-order and specialty pharmacy formats.

Breakup by Ownership:

• Independent: Locally owned pharmacies that offer personalized service and close relationships with patients in their communities.
• Chain: Multi-location pharmacy networks operating under common ownership, benefiting from scale, wide geographic reach, and purchasing power.

Breakup by Region:

• Northeast: A densely populated region with a large base of hospitals, health systems, and pharmacy locations serving demand for prescription and OTC products.
• Midwest: A region combining urban centers and smaller communities, where chain and independent pharmacies both play an important role in medication access.
• South: A large and growing region whose population base supports sustained demand for prescription medications and pharmacy services.
• West: A region with strong adoption of digital health, telehealth, and ePharmacy solutions alongside a broad network of retail pharmacies.

Key Challenges and Growth Opportunities in the United States Pharmacy Market

The United States pharmacy market faces challenges including thin prescription reimbursement, rising operating costs, and intensifying competition from big-box retailers and online pharmacies, which are pressuring traditional drugstore models.

Despite these challenges, the market offers considerable growth opportunities driven by the rising burden of chronic diseases, an aging population, the expansion of ePharmacy and telehealth services, and the growth of specialty drugs and personalized medicine. The broader role of pharmacists in immunizations and chronic disease management is also expected to support long-term growth.

Competitive Landscape

The United States pharmacy market is highly competitive and is shaped by large national chains and retailers such as CVS Health, Walgreens, Walmart, and Kroger, alongside digital entrants such as Amazon Pharmacy. Key players focus on expanding services, strengthening home delivery and online ordering, and integrating healthcare offerings. The IMARC report examines the competitive landscape, including market structure, key player positioning, top winning strategies, a competitive dashboard, and company evaluation quadrant, along with profiles of the major companies.

Recent Developments in the United States Pharmacy Market

• August 2025: Sycamore Partners completed its acquisition of Walgreens Boots Alliance in a deal valued at around USD 10 billion, taking Walgreens private as a standalone company under new CEO Mike Motz.
• November 2020: Amazon launched Amazon Pharmacy, allowing prescriptions to be sent to Amazon with free two-day delivery for Prime members.
• June 2018: Amazon acquired online pharmacy PillPack for around USD 1 billion, marking its entry into the prescription pharmacy market.

Author IMARC Group

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multidisciplinary team of industry experts, IMARC delivers reliable market intelligence across sectors including Chemicals and Materials, Healthcare, Technology, Agriculture, and Retail.

Contact Us:

IMARC Group

Email: sales@imarcgroup.com

United States: +1-201-971-6302